FDA Approves New Plasma-derived Product to Treat Complications of Smallpox Vaccination

FDA has approved Vaccinia Immune Globulin Intravenous (VIGIV) -- the first intravenous human plasma-derived product available to treat certain rare complications of smallpox vaccination... click link for more info.

Continue to FDA Approves New Plasma-derived Product to Treat Complications of Smallpox Vaccination on Medical News Today.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz